124 related articles for article (PubMed ID: 28698826)
1. Expression, refolding and spectroscopic characterization of fibronectin type III (FnIII)-homology domains derived from human fibronectin leucine rich transmembrane protein (FLRT)-1, -2, and -3.
Yang L; Hansen Falkesgaard M; Thulstrup PW; Walmod PS; Lo Leggio L; Krighaar Rasmussen K
PeerJ; 2017; 5():e3550. PubMed ID: 28698826
[TBL] [Abstract][Full Text] [Related]
2. A role for fibronectin-leucine-rich transmembrane cell-surface proteins in homotypic cell adhesion.
Karaulanov EE; Böttcher RT; Niehrs C
EMBO Rep; 2006 Mar; 7(3):283-90. PubMed ID: 16440004
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous Unfolding-Refolding of Fibronectin Type III Domains Assayed by Thiol Exchange: THERMODYNAMIC STABILITY CORRELATES WITH RATES OF UNFOLDING RATHER THAN FOLDING.
Shah R; Ohashi T; Erickson HP; Oas TG
J Biol Chem; 2017 Jan; 292(3):955-966. PubMed ID: 27909052
[TBL] [Abstract][Full Text] [Related]
4. Leucine-rich repeat, immunoglobulin-like and transmembrane domain 3 (LRIT3) is a modulator of FGFR1.
Kim SD; Liu JL; Roscioli T; Buckley MF; Yagnik G; Boyadjiev SA; Kim J
FEBS Lett; 2012 May; 586(10):1516-21. PubMed ID: 22673519
[TBL] [Abstract][Full Text] [Related]
5. Regulated expression of FLRT genes implies a functional role in the regulation of FGF signalling during mouse development.
Haines BP; Wheldon LM; Summerbell D; Heath JK; Rigby PW
Dev Biol; 2006 Sep; 297(1):14-25. PubMed ID: 16872596
[TBL] [Abstract][Full Text] [Related]
6. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
Afzal AJ; Lightfoot DA
Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
[TBL] [Abstract][Full Text] [Related]
7. Biochemical dissection of Anosmin-1 interaction with FGFR1 and components of the extracellular matrix.
Murcia-Belmonte V; Esteban PF; García-González D; De Castro F
J Neurochem; 2010 Dec; 115(5):1256-65. PubMed ID: 20874775
[TBL] [Abstract][Full Text] [Related]
8. Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.
Vancraenenbroeck R; Lobbestael E; Weeks SD; Strelkov SV; Baekelandt V; Taymans JM; De Maeyer M
Biochim Biophys Acta; 2012 Mar; 1824(3):450-60. PubMed ID: 22251894
[TBL] [Abstract][Full Text] [Related]
9. Expression of fibronectin-binding protein of L. acidophilus NCFM and in vitro refolding to adhesion capable native-like protein from inclusion bodies.
Bisht S; Singh KS; Choudhary R; Kumar S; Grover S; Mohanty AK; Pande V; Kaushik JK
Protein Expr Purif; 2018 May; 145():7-13. PubMed ID: 29229289
[TBL] [Abstract][Full Text] [Related]
10. NCAM2 Fibronectin type-III domains form a rigid structure that binds and activates the Fibroblast Growth Factor Receptor.
Rasmussen KK; Falkesgaard MH; Winther M; Roed NK; Quistgaard CL; Teisen MN; Edslev SM; Petersen DL; Aljubouri A; Christensen C; Thulstrup PW; Lo Leggio L; Teilum K; Walmod PS
Sci Rep; 2018 Jun; 8(1):8957. PubMed ID: 29895898
[TBL] [Abstract][Full Text] [Related]
11. The guidance and adhesion protein FLRT2 dimerizes in cis via dual small-X
Jackson V; Hermann J; Tynan CJ; Rolfe DJ; Corey RA; Duncan AL; Noriega M; Chu A; Kalli AC; Jones EY; Sansom MSP; Martin-Fernandez ML; Seiradake E; Chavent M
Structure; 2022 Sep; 30(9):1354-1365.e5. PubMed ID: 35700726
[TBL] [Abstract][Full Text] [Related]
12. The mechanical hierarchies of fibronectin observed with single-molecule AFM.
Oberhauser AF; Badilla-Fernandez C; Carrion-Vazquez M; Fernandez JM
J Mol Biol; 2002 May; 319(2):433-47. PubMed ID: 12051919
[TBL] [Abstract][Full Text] [Related]
13. Identification of the domain in the human interleukin-11 receptor that mediates ligand binding.
Schleinkofer K; Dingley A; Tacken I; Federwisch M; Müller-Newen G; Heinrich PC; Vusio P; Jacques Y; Grötzinger J
J Mol Biol; 2001 Feb; 306(2):263-74. PubMed ID: 11237599
[TBL] [Abstract][Full Text] [Related]
14. A third fibronectin type III domain in the extracellular region of the insulin receptor family.
Marino-Buslje C; Mizuguchi K; Siddle K; Blundell TL
FEBS Lett; 1998 Dec; 441(2):331-6. PubMed ID: 9883910
[TBL] [Abstract][Full Text] [Related]
15. When a module is not a domain: the case of the REJ module and the redefinition of the architecture of polycystin-1.
Schröder S; Fraternali F; Quan X; Scott D; Qian F; Pfuhl M
Biochem J; 2011 May; 435(3):651-60. PubMed ID: 21314639
[TBL] [Abstract][Full Text] [Related]
16. Engineering surfaces for substrate-mediated gene delivery using recombinant proteins.
Rea JC; Gibly RF; Davis NE; Barron AE; Shea LD
Biomacromolecules; 2009 Oct; 10(10):2779-86. PubMed ID: 19775146
[TBL] [Abstract][Full Text] [Related]
17. The effect of boundary selection on the stability and folding of the third fibronectin type III domain from human tenascin.
Hamill SJ; Meekhof AE; Clarke J
Biochemistry; 1998 Jun; 37(22):8071-9. PubMed ID: 9609701
[TBL] [Abstract][Full Text] [Related]
18. Dimerization of Tie2 mediated by its membrane-proximal FNIII domains.
Moore JO; Lemmon MA; Ferguson KM
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4382-4387. PubMed ID: 28396397
[TBL] [Abstract][Full Text] [Related]
19. The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells.
Cho C; Horzempa C; Jones D; McKeown-Longo PJ
BMC Cancer; 2016 Aug; 16():574. PubMed ID: 27484721
[TBL] [Abstract][Full Text] [Related]
20. Cloning, expression, purification, and immunoblotting analysis of recombinant type III fibronectin domains of human oncostatin M receptor.
Vempati RK
Mol Biol Rep; 2023 May; 50(5):4735-4741. PubMed ID: 36929287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
